Register now for the next episode of “Dr. Gilbert Hosts” where APDA’s Chief Scientific Officer, Dr. Rebecca Gilbert, speaks with Dr. Carlie Tanner about the effects of the environment on the risk of developing PD. Dr. Tanner is the Associate Director at the Parkinson’s Disease Research Education and Clinical Center at the San Francisco VA. The webinar is scheduled for Wednesday, June 16, 9am PT.
In this ongoing webinar series by the American Parkinson Disease Association (APDA), Dr. Gilbert speaks with experts in the Parkinson’s disease (PD) community and opens the conversation up to your questions.
Dr. Gilbert Hosts: Parkinson’s Research & the Environment
Wednesday, June 16, 2021
12:00 PM ET11:00 AM CT10:00 AM MT9:00 AM PT
This webinar will be broadcast on YouTube. After registering, you will receive a confirmation email containing information about how to view the broadcast.
About the connection between PD and environmental factors
Check out these APDA resources:
Environmental Research at the NIH: Hear what Dr. Koroshetz, director of the NINDS, says about PD research at the NIH, including the relationship between PD and the environment.
Pesticides and PD:Dr. Gilbert delves into the topic of pesticides and other environmental concerns that might increase risk of PD. She discusses rural living, specific pesticides, other pollutants, veterans exposure to pesticides, and more.
Military exposure to pesticides: Veterans may be at an increased risk of PD because of their service. Evidence suggests that one cause of PD may be exposure to pesticides or herbicides (i.e. Agent Orange).
This booklet explains that connection, provides information about PD and its treatments, as well as the benefits available to veterans who have PD.
About Dr. Carlie Tanner
Caroline M. Tanner, MD, PhD, FAAN, trained in neurology and movement disorders at Rush University in Chicago. She received her Ph.D. from the University of California, Berkeley. She directed clinical research at the Parkinson’s Institute from 1990-2013. She is now Professor of Neurology at the University of California, San Francisco and the Associate Director at the Parkinson’s Disease Research Education and Clinical Center at the San Francisco VA.
Dr. Tanner’s clinical practice specializes in movement disorders. Her research interests include descriptive epidemiology, environmental and genetic determinants, biomarkers, early detection, non-motor disease features and trials for the secondary prevention, disease modification and symptomatic treatment of movement disorders and neurodegenerative diseases. She is past co-chair of the Parkinson Study Group (PSG) and has conducted numerous clinical trials with PSG and others. Dr. Tanner and her colleagues have identified associations between exposures including certain pesticides, solvents and persistent environmental pollutants and increased risk of Parkinson’s disease, and identified gene-environment interactions. She is the principal investigator of the Fox Insight online study. She serves on the executive steering committee of the Parkinson’s Progression Markers Initiative (PPMI) study and leads the prospective online data collection.